Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 291.80
Bid: 294.20
Ask: 294.80
Change: 2.40 (0.83%)
Spread: 0.60 (0.204%)
Open: 295.60
High: 295.60
Low: 287.20
Prev. Close: 289.40
PETS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 FY24 Trading Statement

3 Aug 2023 07:00

RNS Number : 1341I
Pets At Home Group Plc
03 August 2023
 

 

FOR IMMEDIATE RELEASE, 03 AUGUST 2023

Pets at Home Group Plc: Q1 FY24 Trading Statement

for the 16 week period to 20 July 2023

Strong sales momentum and further strategic progress

 

Financial Highlights

Consumer revenue1 up 10.2% to £568.2m supported by both volume and value growth.

Consumer numbers continued to grow with our active VIP base increasing 4% to 7.7m, with over 22,000 new Puppy & Kitten sign ups and 18,000 new pet registrations a week in our Vet Group.

Total Group revenue growth of 7.9% to £436.8m, with Group like-for-like2 (LFL) revenue up 7.9%.

Vet Group revenue was up 16.3%, with LFL2 of 16.6%, increasingly supported by number of visits (as we increased vet capacity), improving mix and continued growth in average spend.

Retail revenue growth of 7.1%, and LFL2 up 7.1%. Our food category remains in volume growth across grocery and premium categories supported by further progress in our relative price position. Accessories trends were consistent with previous quarters, as expected.

 

Business Highlights

Opened 2 new pet care centres with in-store JV vets, both under our new integrated brand, and completed 9 refits, including our Leeds Birstall centre, with a significant extension of an existing vet hospital, providing 24-hour patient care, additional services and consult rooms, and training facilties.

Continued progress in the development of our digital platform, remaining on track for cut over of our consumer app and website later this year, a key foundation for growth in the years ahead.

We also launched nutrition subscription capability in-store resulting in accelerated Easy Repeat sign ups. We also relaunched our care plans in the quarter which have seen strong consumer uptake.

As part of our food strategy, we continued the rollout of new freezer space across the estate, alongside the introduction of new ranges, resulting in good sales uplift in our frozen category.

Encouraging activity within vet recruitment and retention with turnover down 7% YoY, the impacts of which are already being seen in our revenue growth. We have doubled the number of graduate places on offer and have filled over two thirds to date, and our JV partner pipeline is in very strong shape

Good progress in our sustainability agenda. We now have fed over 1.5m pets through our foodbank partnership with Blue Cross, launched a sustainable anaesthetic programme, and raised £1.5m for charities in the quarter. We are also pleased to be included in the FTSE4Good Index.

 

Current trading and outlook

We make no change to guidance for FY24 and remain comfortable with current analyst expectations for Group underlying PBT*, noting that our H1 profits will carry additional costs to ramp up the new DC (£6m) and the cost of our brand relaunch (£2m), both in line with our plan.

In addition, in line with our strategy to integrate our business, we made the decision to consolidate our vet and retail support offices. This move will result in a £3m one-off transition cost in the year.

Our balance sheet remains robust and we are progressing our £50m share buyback programme.

 

*Consensus currently £136.8m, with a range of £132m to £142m.

 

Lyssa McGowan, Chief Executive Officer, commented:

Our performance in the first quarter has been encouraging. The quality of our growth has remained strong as we grew transaction volumes and continued to acquire new consumers at an impressive rate, as our compelling value, range and service continues to resonate with consumers.

It has also been a quarter of steady delivery against our strategic plan we set out in May. We have expanded and enhanced our physical estate, made good progress in the development of our digital platform, and continued the transition to our new distribution facility, as we execute on our ambition to build the world's best pet care platform.

 

1. Consumer revenue includes total revenue across the Group including consumer sales made by Joint Venture vet practices, and therefore differs to the fee income recognised within Vet Group statutory revenue.

2. Like-for-like revenue comprises total revenue in a financial period compared to revenue achieved in a prior period, for stores, omnichannel operations, grooming salons, and vet practices that have been trading for 52 weeks or more.

 

Our next scheduled update will be our FY24 interim results announcement on 28 November 2023.

 

Investor Relations Enquiries

Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations

+44 (0) 7740 361 849

Chris Ridgway, Head of Investor Relations

+44 (0) 7788 783 925

Media Enquiries

Pets at Home Group Plc:

Natalie Cullington, Head of Communications

+44 (0) 7974 594 701

Citigate Dewe Rogerson:

Lorna Cobbett

+44 (0) 7771 344 781

Angharad Couch

+44 (0) 7507 643 004

 

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from our 458 stores, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with 445 veterinary General Practices located both in our stores and in standalone locations. For more information visit: http://investors.petsathome.com/

 

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUWROSUWRAR
Date   Source Headline
2nd Apr 20248:29 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSFY24 pre-close statement
14th Mar 202410:36 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 202410:31 amRNSResponse to CMA announcement
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20249:43 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20244:51 pmRNSHolding(s) in Company
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSQ3 FY24 Trading Statement
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.